Immunoglobulins Anti-Igg (H+L) Rats Labeled with Peroxidase

Peroxidase-labeled anti-rat IgG (H+L) immunoglobulins: development and application

Introduction

Immunoglobulins are key components of the immune system, responsible for protecting the body from infections and other pathological processes. They are specific protein molecules that can bind to various antigens and participate in their destruction or removal from the body. In recent years, research in the field of immunoglobulins has led to the development of new labeling and diagnostic methods, one of which is peroxidase labeling of immunoglobulins.

Description

Immunoglobulins against rat IgG (H+L), labeled with peroxidase, are a product developed in Russia by the Research Institute of EM, an enterprise for the production of bacterial preparations named after. N.F. Gamaleya. These immunoglobulins belong to the pharmaceutical group of immunoglobulins and are intended for use for diagnostic purposes.

The peroxidase labeling procedure enables rat anti-IgG (H+L) immunoglobulins to detect and bind to antigens, and then uses peroxidase to visualize this binding. Peroxidase is an enzyme that catalyzes oxidative reactions leading to the formation of a colored product. Thus, labeled immunoglobulins allow visualization of the presence or absence of a specific antigen in a sample.

Application

Peroxidase-labeled anti-rat IgG (H+L) immunoglobulins have a wide range of applications in clinical diagnostics. They can be used to identify antigens associated with various diseases, including infectious diseases, autoimmune disorders and tumors. Labeled immunoglobulins enable enzyme-linked immunosorbent assays, such as enzyme-linked immunosorbent assay (ELISA) and immunochemical assays, to detect and quantify antigens in clinical samples.

The dosage form of immunoglobulins against rat IgG (H+L), labeled with peroxidase, is presented in the form of a diagnostic dry mass in porous ampoules of 0.2 ml. This helps maintain the stability and durability of the product, and also ensures ease of use in laboratory conditions.

Conclusion

Peroxidase-labeled anti-rat IgG (H+L) immunoglobulins represent an innovative product in the field of diagnostics and research. Their use makes it possible to identify antigens and conduct qualitative and quantitative analyzes in clinical practice. The production and development of these immunoglobulins is carried out in Russia, by the leading research institute Scientific Research Institute of EM and the enterprise for the production of bacterial preparations named after. N.F. Gamaleya. Due to their specificity and visualization of results, peroxidase-labeled anti-rat IgG (H+L) immunoglobulins are a valuable tool in modern medicine and scientific research.